Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chu Chieh Hsia is active.

Publication


Featured researches published by Chu Chieh Hsia.


Transfusion | 2003

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

Robin Biswas; Edward Tabor; Chu Chieh Hsia; David J. Wright; Megan E. Laycock; Eberhard W. Fiebig; Lorraine Peddada; Richard Smith; George B. Schreiber; Jay S. Epstein; George J. Nemo; Michael P. Busch

BACKGROUND: A study was designed to estimate relative analytic sensitivity and window‐period (WP) closure and to project incremental yield of newer HBsAg tests, pooled‐sample NAT, and single‐sample NAT, compared to currently licensed HBsAg tests.


Hepatology | 1995

Expression of transforming growth factor alpha in the liver before and after interferon alfa therapy for chronic hepatitis B

Yosuke Morimitsu; David E. Kleiner; Hari S. Conjeevaram; Chu Chieh Hsia; Adrian M. Di Bisceglie; Edward Tabor

The effect of interferon alfa (IFN‐α) therapy on the expression of transforming growth factor alpha (TGF‐α) in the liver during chronic hepatitis B was investigated. Serial liver biopsy specimens were evaluated from 35 patients who had participated in a randomized, controlled trial of recombinant human IFN‐α for the treatment of chronic hepatitis B. Percutaneous liver biopsy specimens obtained before and 1 year after entry in the trial were sectioned and stained with a monoclonal antibody to TGF‐α in an avidin‐biotin‐peroxidase‐complex system. The expression of TGF‐α in each section was evaluated blindly (with respect to treatment group and order of biopsies) and was numerically scored. There was no significant difference in TGF‐α expression before or after therapy between 13 patients receiving daily IFN‐α, 13 receiving alternate‐day IFN‐α, and 9 receiving no therapy. Sustained clearance of HBV‐DNA and DNA polymerase activity occurred in 8 of 26 treated patients (“responders”); the 18 other patients were “nonresponders.” Expression of TGF‐α before IFN‐α therapy was significantly higher in responders than in nonresponders; after IFN‐α therapy, TGF‐α expression decreased significantly among responders compared with nonresponders and untreated controls. Thus, the level of expression of TGF‐α in the liver, which was correlated with the severity of inflammation in the liver in this study, appeared to be predictive of the response to IFN‐α therapy in chronic hepatitis B, with a higher level of expression indicating a greater likelihood that the patient would respond. (HEPATOLOGY 1995; 22:1021–1026.).


Liver | 1999

Vascularization of small hepatocellular carcinomas : correlation with differentiation

Yutaka Nakashima; Osamu Nakashima; Chu Chieh Hsia; Masamichi Kojiro; Edward Tabor


Biochemical and Biophysical Research Communications | 1997

Deletion Mutants of the Hepatitis B Virus X Gene in Human Hepatocellular Carcinoma

Chu Chieh Hsia; Yutaka Nakashima; Edward Tabor


Journal of the National Cancer Institute | 1992

Mutations of p53 gene in hepatocellular carcinoma : roles of hepatitis B virus and aflatoxin contamination in the diet

Chu Chieh Hsia; David E. Kleiner; Constantine A. Axiotis; Adrian M. Di Bisceglie; Abraham M. Y. Nomura; Grant N. Stemmermann; Edward Tabor


Oncology Reports | 2000

Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma.

Chu Chieh Hsia; Y Nakashima; S S Thorgeirsson; C C Harris; M Minemura; S. Momosaki; N J Wang; E Tabor


Biochemical and Biophysical Research Communications | 2007

Microarray multiplex assay for the simultaneous detection and discrimination of hepatitis B, hepatitis C, and human immunodeficiency type-1 viruses in human blood samples

Chu Chieh Hsia; Vladimir E. Chizhikov; Amy X. Yang; Angamuthu Selvapandiyan; Indira Hewlett; Robert Duncan; Raj K. Puri; Hira L. Nakhasi; Gerardo G. Kaplan


Biochemical and Biophysical Research Communications | 1997

Binding of wild-type p53 by topoisomerase II and overexpression of topoisomerase II in human hepatocellular carcinoma.

Hao Yuwen; Chu Chieh Hsia; Yutaka Nakashima; Amy Evangelista; Edward Tabor


International Journal of Oncology | 1998

p53 overexpression in small hepatocellular carcinomas containing two different histologic grades.

Y. Nakashima; Chu Chieh Hsia; H. Yuwen; M. Minemura; O. Nakashima; M. Kojiro; E. Tabor


Archive | 2007

Detection and discrimination of hepatitis c virus, human immunodeficiency virus type-1 and hepatitis b virus

Chu Chieh Hsia; Gerardo G. Kaplan; Vladimir E. Chizhikov; Angamurhu Selvapandiyan; Amy X. Yang; Hira L. Nakhasi; Raj K. Puri

Collaboration


Dive into the Chu Chieh Hsia's collaboration.

Top Co-Authors

Avatar

Edward Tabor

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Yutaka Nakashima

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Amy X. Yang

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

David E. Kleiner

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Gerardo G. Kaplan

Center for Biologics Evaluation and Research

View shared research outputs
Top Co-Authors

Avatar

Hira L. Nakhasi

Center for Biologics Evaluation and Research

View shared research outputs
Top Co-Authors

Avatar

Raj K. Puri

Center for Biologics Evaluation and Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge